Caraco Pharmaceutical Labs (CPD) Posts Q3 EPS of $0.17
Caraco Pharmaceutical Laboratories Ltd. (AMEX: CPD) reports Q2 EPS of $0.17, versus the analyst estimate of ($0.17). Revenue for the quarter was $78.38 million, which compares to the estimate of $45.84 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- PVH Corp. (PVH) Tops Q1 EPS by 4c; Guides FY12 EPS
- VeriFone Systems (PAY) Tops Q2 EPS by 3c; Guides Q3, FY12
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
